INS and diabetes mellitus: Chloroquine has also been observed to alter the trafficking and fusion of glutamate transporter 4 (GLUT4) with the plasmalemma and to inhibit endolysosomal degradation of insulin (and other molecules, as expected), which cause insulin–insulin receptor accumulation in endosomes, for which this drug has also been studied in the context of diabetes [151,152].